PDE4D and Alzheimer disease: GEBR-8a and GEBR-32a show 2–3-fold selectivity for PDE4D over other PDE4 subtypes and have also been shown to increase hippocampal cAMP and enhance memory performance in transgenic AD mice with reduced potential for emesis [60, 61].